GLP-1 medications like Ozempic and Wegovy show promise in treating Depression, addiction, and cognitive issues. But what are GLP-1 drugs exactly, how do they work, what promise and results have
When Antidepressants Stop Working: An Update on “Poop Out”
Antidepressants have brought relief to millions of people struggling with major depressive disorder (MDD). They can restore energy, stabilize mood, and allow patients to reclaim parts of their lives that
Does Ketamine Improve Quality of Life for People with Depression?
When you hear the word “ketamine,” you might think of club drugs or even anesthesia. But in recent years, ketamine—and its close cousin, esketamine (Spravato)—has been receiving much attention in
Depression and Cardiovascular Disease
Depression and cardiovascular disease (CVD) are two of the most pervasive and disabling health conditions globally—and mounting evidence shows that they are deeply interconnected. Heart disease continues to be the
Breaking the Cycle of Treatment-Resistant Depression: Real-World Lessons from Europe
Treatment-resistant Depression (TRD) poses a significant challenge in mental health care. Despite the availability of various antidepressant therapies, a substantial subset of patients fails to achieve response or remission, leading
Enhancing Depression Treatment: The Synergistic Potential of TMS and Antidepressants
Major Depressive Disorder (MDD) stands as a leading cause of disability worldwide, affecting millions and imposing significant personal and societal burdens. Traditional treatment modalities, primarily pharmacotherapy with antidepressants, have shown
Can Exercise Treat Depression?
Depression: A Growing Global Challenge Depression is one of the world’s leading causes of disability, affecting over 280 million people worldwide. Traditional treatments—such as antidepressants and psychotherapy—help many, but they’re
Antidepressant Weight Gain: A Recent Study
In the landscape of mental health treatment, antidepressant medications play a crucial role in managing conditions like Depression. However, patients and clinicians often express concern about potential side effects, with
Can Spravato (Esketamine) Transform Treatment-Resistant Depression? Insights from a Recent Study
Treatment-resistant Depression (TRD) remains one of Psychiatry’s most complex clinical challenges. Standard antidepressants often fail to bring relief to approximately one-third of patients with Major depressive disorder (MDD). In this
Comparing TMS With Other Antidepressant Treatments
In the evolving landscape of mental health treatments, finding effective solutions for treatment-resistant Depression (TRD) remains a significant challenge. As many as one third of patients with major depressive disorder